Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Fig. 1

Bacterial microbiota α-diversity biodiversity analysis. A Experimental design and procedure of this study. B The establishment of sham and type 2 SBS rat model. C Rarefaction curves of each sample. D OTU counts analysis among groups. Bacterial α-diversity estimated by Chao [E], ACE [F], Shannon’s diversity [G], Simpson’ diversity [H] and Good’s coverage [I]. D-I Median and IQR were shown. The abnormal value is shown as ‘o’. *P < 0.05; **P < 0.01 compared with the Sham group

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us